CRISPR-Mediated Cleavage of Enzyme-Oligonucleotide Conjugates for Detection of Target Analytes
CRISPR-Mediated Cleavage of Enzyme-Oligonucleotide Conjugates for Detection of Target Analytes
NU 2021-068
INVENTORS
- Chad Mirkin*

- Devleena Samanta
- Sasha Ebrahimi
SHORT DESCRIPTION
This technology leverages CRISPR-mediated cleavage of enzyme-oligonucleotide conjugates to enable sensitive, colorimetric detection of target analytes without the need for specialized equipment or stringent temperature conditions.
BACKGROUND
Current diagnostic platforms, such as PCR and ELISA, often require complex, multi-step processes, specific temperature conditions, and advanced instrumentation, limiting their use to centralized facilities. This invention addresses these limitations by providing a simplified, point-of-care diagnostic solution that can detect nucleic acid and non-nucleic acid analytes efficiently and effectively.
ABSTRACT
Northwestern researchers have developed a novel diagnostic strategy utilizing CRISPR-mediated cleavage of surface-bound enzyme-oligonucleotide conjugates. Upon the presence of a target analyte, a nucleic acid sequence binds to a CRISPR RNAse or DNAse, such as Cas13 or Cas12, pre-complexed with a guide RNA. This interaction activates the CRISPR enzyme, leading to the cleavage of the conjugates and the release of enzymes into solution. The subsequent treatment with an enzyme substrate produces a chromogenic, fluorogenic, or luminescent signal, which is directly proportional to the target concentration. This approach facilitates rapid and routine detection of viral and bacterial infections, disease biomarkers, and monitoring of disease progression or therapeutic response.
APPLICATIONS
- Detecting nucleic-acid and non-nucleic acids in solution and clinical samples
- Quantifying levels of analytes in serum
ADVANTAGES
- Specialized equipment not necessary
- No specific temperature requirement
- Signal amplification without target amplification
- Detectable by the naked eye in some cases
- Simple workflow for at-home or point-of-care use
IP STATUS
Issued US Patent US20240150817A1
PUBLICATION
Samanta, D., Ebrahimi, S.B., Ramani, N., Mirkin, C.A. Enhancing CRISPR-CAS-Mediated Detection of Nucleic Acids and Non-nucleic Acid Targets Using Enzyme-Labeled Reporters. J. Am. Chem. Soc. 2022, 144, 35, 16310-16315.
Patent Information:
| Title |
App Type |
Country |
Serial No. |
Patent No. |
File Date |
Issued Date |
Expire Date |
Categories:
Life Sciences > Biomarkers & Biomedical Research Tools
Keywords:
COVID-19
Diagnostics
Research tool